India is likely to approve the vaccine being developed by AstraZeneca and Oxford University for emergency use by next week after its local manufacturer submitted additional data sought by authorities, the Reuters news agency reported citing two sources with knowledge of the matter. The approval would make India the first country to give the regulatory green light to the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the vaccine’s late-stage trials.

India is likely to approve the vaccine being developed by AstraZeneca and Oxford University for emergency use by next week after its local manufacturer submitted additional data sought by authorities, the Reuters news agency reported citing two sources with knowledge of the matter. The approval would make India the first country to give the regulatory green light to the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the vaccine’s late-stage trials.